Medical Letter on the CDC & FDA
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC & FDA
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Blood Safety
Pathogen inactivation proactively protects the blood supply
July 24th, 2005
Pathogen inactivation proactively protects the blood supply. According to a published report from England, "Although the risk of infection by blood transfusion is relatively low, breakthrough infections still occur. Transfusion-related fatalities caused by infections continue to be reported, and blood is not tested for many potentially dangerous pathogens." "The current paradigm for increasing the safety of the blood supply is the development and implementation of laboratory screening methods and restrictive donor criteria. "When considering the large number of known pathogens and the fact that pathogens continue to emerge,"...
Source: Medical Letter on the CDC & FDA (2005-07-24)
|
